Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Reuters Investment Profile
$20.00
Provider: Wright Reports
$75.00
Provider: GlobalData
$125.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Celltrion, Inc. Acquires Stake in Celltrion Pharm Inc.


Friday, 19 Apr 2013 04:46am EDT 

Celltrion Pharm Inc. announced that Celltrion, Inc. has acquired 4,471,612 shares of Celltrion Pharm Inc. from Celltrion Holdings Co., Ltd., equivalent to a 31.61% stake. After the transaction, Celltrion, Inc. and 23 other investors became the largest shareholder of Celltrion Pharm Inc., replacing Celltrion Holdings Co., Ltd. and 23 individuals. Celltrion, Inc. and 23 other investors currently hold 4,943,408 shares, or 34.97% of Celltrion Pharm Inc.. 

Company Quote

40200.0
50.0 +0.12%
22 Aug 2014